General Information of Drug (ID: DMZID5A)

Drug Name
EN3488
Indication
Disease Entry ICD 11 Status REF
Non-muscle invasive bladder cancer 2C94 Phase 3 [1]
Cross-matching ID
TTD ID
D09KHE

References

1 ClinicalTrials.gov (NCT00406068) Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer. U.S. National Institutes of Health.